Thakkar Roopal
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Thakkar Roopal. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ABBV | EVP, R&D and CSO | Tax Withholding | 4,678 | $205.02 | $959,084 | Feb 28, 2025 |
| ABBV | EVP, R&D and CSO | Award / Grant | 3,348 | — | — | Feb 13, 2025 |
| ABBV | SVP, CMO, GLOBAL THERAPEUTICS | Tax Withholding | 4,914 | $178.99 | $879,557 | Feb 28, 2024 |
| ABBV | EVP, R&D and CSO | Award / Grant | 2,140 | — | — | Feb 15, 2024 |
| ABBV | SVP, CMO, GLOBAL THERAPEUTICS | Award / Grant | 2,138 | — | — | Feb 15, 2024 |